A Case of Anti-Ma2 Encephalitis Presenting with Pendular Torsional Nystagmus.
Vaghi G, Vegezzi E, Bini P, Gastaldi M, Diamanti L, Marchioni E, Colnaghi S.
Cerebellum. 2024 Jun;23(3):1249-1253. doi: 10.1007/s12311-023-01601-w. Epub 2023 Oct 18.
Upbeat nystagmus in anti-Ma2 encephalitis.
Garcia-Reitboeck P, Thompson G, Johns P, Al Wahab Y, Omer S, Griffin C.
Pract Neurol. 2014 Feb;14(1):36-8. doi: 10.1136/practneurol-2013-000524. Epub 2013 Sep 16.
Acute anti-Ma2 paraneoplastic encephalitis associated to pembrolizumab: a case report and review of literature.
Albarrán V, Pozas J, Rodríguez F, Carrasco Á, Corral E, Lage Y, Álvarez-Ballesteros P, Soria A, Garrido P.
Transl Lung Cancer Res. 2021 Jul;10(7):3303-3311. doi: 10.21037/tlcr-21-222.
Anti-Ma2 antibody related paraneoplastic limbic/brain stem encephalitis associated with breast cancer expressing Ma1, Ma2, and Ma3 mRNAs.
Sahashi K, Sakai K, Mano K, Hirose G.
J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1332-5. doi: 10.1136/jnnp.74.9.1332.
Fatal Anti-Ma2 Encephalitis Related to Treatment of Malignant Pleural Mesothelioma With a Combination of Anti-Programmed Death 1 and Anti-Cytotoxic T-Lymphocyte Associated Protein 4 Antibodies.
Du Rusquec P, Peyre A, Toulgoat F, Honnorat J, Raimbourg J.
J Thorac Oncol. 2019 Aug;14(8):e174-e176. doi: 10.1016/j.jtho.2019.03.017.
Review of paraneoplastic syndromes in children.
Ma GM, Chow JS, Taylor GA.
Pediatr Radiol. 2019 Apr;49(4):534-550. doi: 10.1007/s00247-019-04371-y. Epub 2019 Mar 16.
Antibody-positive paraneoplastic neurological syndromes associated with immune checkpoint inhibitors: a systematic review.
Zhang L, Fan S, Wang J, Ren H, Guan H.
J Neurol. 2025 Mar 5;272(3):249. doi: 10.1007/s00415-025-12992-7.
Autoimmune encephalitis associated with Ma2 antibodies and immune checkpoint inhibitor therapy.
Lyons S, Joyce R, Moynagh P, O'Donnell L, Blazkova S, Counihan TJ.
Pract Neurol. 2020 May;20(3):256-259. doi: 10.1136/practneurol-2019-002464. Epub 2020 Apr 17.
Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.
Grativvol RS, Cavalcante WCP, Castro LHM, Nitrini R, Simabukuro MM.
Curr Oncol Rep. 2018 Nov 10;20(11):92. doi: 10.1007/s11912-018-0721-y.
Central nervous system adverse events of immune checkpoint inhibitors.
Farina A, Villagrán-García M, Vogrig A, Joubert B.
Curr Opin Neurol. 2024 Jun 1;37(3):345-352. doi: 10.1097/WCO.0000000000001259. Epub 2024 Mar 14.
